Invicta Diagnostic schedules H2 FY26 earnings call on May 23

1 min read     Updated on 20 May 2026, 10:23 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Invicta Diagnostic Limited will hold a conference call on May 23, 2026, at 12:00 PM IST to discuss its H2 FY26 performance. CFO Rohit Prakash Srivastava will lead the session.

powered bylight_fuzz_icon
40798391

*this image is generated using AI for illustrative purposes only.

Invicta Diagnostic Limited has scheduled an earnings conference call to discuss its financial performance for the half-year ended March 31, 2026. The meeting will take place on May 23, 2026, at 12:00 PM IST, pursuant to Regulation 30(6) read with point 15(a) of Para A Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Conference Call Details

The conference call is open to investors and analysts. It will provide an overview of the company's operational and financial results for the specified period. Participants are advised to dial in 10 minutes prior to the scheduled start time to ensure a timely connection.

Joining Information

Access Type Details
Universal Dial In +91 22 6280 1239, +91 22 7115 8140
Online Registration Diamond Pass Login Available
Date & Time May 23, 2026, 12:00 PM Onwards

Management Participation

The discussion will be led by key members of the company's management team. The primary speaker for the session will be Mr. Rohit Prakash Srivastava, who serves as the Chief Financial Officer & Whole Time Director of Invicta Diagnostic Limited .

The company has stated that certain statements made during the call may be forward-looking and subject to risks and uncertainties. Actual results may differ materially from those expressed or implied during the discussion.

Historical Stock Returns for Invicta Diagnostic

1 Day5 Days1 Month6 Months1 Year5 Years
-4.98%-25.31%-17.32%-30.87%-30.87%-30.87%

How has Invicta Diagnostic Limited's revenue growth trajectory compared to peers in the diagnostic sector over the past few quarters?

What expansion plans or capital allocation strategies might management reveal for the second half of FY2026?

How could rising competition from larger diagnostic chains like Dr. Lal PathLabs or Metropolis impact Invicta's margins going forward?

Invicta Diagnostic Appoints M/s. Shrenik Nagaonkar & Associates as Secretarial Auditor for Five-Year Term

1 min read     Updated on 14 May 2026, 10:56 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Invicta Diagnostic Limited's Board of Directors appointed M/s. Shrenik Nagaonkar & Associates, Company Secretaries, as Secretarial Auditor for a five-year term from FY 2025-26 to FY 2029-30, at its meeting held on May 13, 2026. The appointment was made in compliance with the Companies Act, 2013 and SEBI (LODR) Regulations, 2015, and is subject to shareholder approval at the ensuing Annual General Meeting. Mr. Shrenik Nagaonkar, the firm's proprietor, holds over 19 years of experience in corporate governance, corporate laws, security laws, and capital markets, and is a fellow member of the Institute of Company Secretaries of India.

powered bylight_fuzz_icon
40282000

*this image is generated using AI for illustrative purposes only.

Invicta Diagnostic Limited announced the appointment of M/s. Shrenik Nagaonkar & Associates, Company Secretaries, as its Secretarial Auditor, following a resolution passed at the Board of Directors meeting held on May 13, 2026. The appointment covers a term of five financial years, from FY 2025-26 to FY 2029-30, and will be placed before shareholders at the ensuing Annual General Meeting for approval. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Details

The Board meeting commenced at 7:30 p.m. (IST) and concluded at 8:20 p.m. (IST) on May 13, 2026. The appointment was communicated to the National Stock Exchange of India Limited by Sanket Vinod Jain, Chairman and Non-Executive Director of the company, from Mumbai.

Appointment Details

The key details of the appointment, as disclosed in Annexure I filed with the exchange, are summarised below:

Parameter: Details
Name: M/s. Shrenik Nagaonkar & Associates
Designation: Secretarial Auditor
Date of Appointment: Wednesday, 13 May, 2026
Term of Appointment: 5 (Five) years — FY 2025-26 to FY 2029-30
Reason for Appointment: Compliance with Companies Act, 2013 & SEBI (LODR) Regulations, 2015
Equity Shares Held in Company: NIL
Relationship with Directors: NIL

Profile of the Secretarial Auditor

Mr. Shrenik Nagaonkar is the proprietor of M/s. Shrenik Nagaonkar & Associates. He brings more than 19 years of experience in corporate governance, encompassing corporate laws, security laws, and capital markets. He is a fellow member of the Institute of Company Secretaries of India and holds a Master of Business Administration with specialisation in Finance. The firm is noted to be a peer-reviewed firm.

Regulatory Compliance

The appointment has been made to comply with the provisions of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. As required under Regulation 30 of the Listing Regulations, the company has filed the relevant disclosures with the stock exchange. The appointment remains subject to shareholder ratification at the forthcoming Annual General Meeting.

Historical Stock Returns for Invicta Diagnostic

1 Day5 Days1 Month6 Months1 Year5 Years
-4.98%-25.31%-17.32%-30.87%-30.87%-30.87%

How might the appointment of a seasoned secretarial auditor with capital markets expertise influence Invicta Diagnostic's future compliance posture and potential regulatory actions?

Will shareholder approval of this appointment at the AGM signal broader confidence in Invicta Diagnostic's corporate governance reforms?

Could this strengthened compliance framework position Invicta Diagnostic for any upcoming fundraising activities, exchange upgrades, or regulatory filings?

More News on Invicta Diagnostic

1 Year Returns:-30.87%